The associated genes have known implications in psychiatric disorders, lipid or BMI measurements, or drug responses, including BICD1 and CSMD1 (olanzapine-induced TC changes); GADL1 (risperidone-induced BMI changes); SIPA1L2 (quetiapine-induced HDL changes); and RAB38, CDH23, AMPH, FOXN3, APBB2, C1R and LRCOL1 (paliperidone-induced LDL changes). The gene discussed is FOXN3; the disease is psychiatric disorder.